AP – Peregrine Pharmaceuticals Inc. said Thursday it cut its 2010 fiscal second-quarter loss nearly in half as revenue from manufacturing services and government payments for the antivirus drug candidate bavituximab increased sharply.

Read the original here:
Peregrine cuts 2Q loss nearly in half on revenue
(AP)